FDA approves ocrelizumab

/About-Us/MSF-News-Articles/43.aspx?lang=en-US 29/03/2017 10:23:23 a. m.

Study: effects of estrogen treatment combat MS in mice

/About-Us/MSF-News-Articles/105.aspx?lang=en-US 17/01/2018 10:04:37 a. m.

Adapting to MS’ Parenting Challenges

/Magazine/Magazine-Items/Posted/Adapting-to-MS’-Parenting-Challenges.aspx?lang=en-US 18/04/2017 03:29:18 p. m.

Disability.gov – A One-Click Resource

/Magazine/Magazine-Items/Posted/Disability-gov-–-A-One-Click-Resource.aspx?lang=en-US 18/04/2017 03:28:56 p. m.

Researchers seek participants for mental health services survey

/About-Us/MSF-News-Articles/2308.aspx?lang=en-US 26/02/2021 11:30:33 a. m.

Study: Black people may respond differently to common MS therapy than white people

/About-Us/MSF-News-Articles/2312.aspx?lang=en-US 20/04/2021 11:19:45 a. m.

Study: Low levels of a simple sugar may be a MS biomarker

/About-Us/MSF-News-Articles/2318.aspx?lang=en-US 14/05/2021 11:15:05 a. m.

Study suggests Mediterranean diet, lower cognitive impairment link

/About-Us/MSF-News-Articles/2023/2382.aspx?lang=en-US 03/03/2023 03:22:59 p. m.

Treating radiologically isolated syndrome may reduce MS risk

/About-Us/MSF-News-Articles/2023/2428.aspx?lang=en-US 11/10/2023 10:31:19 a. m.

Study shows potential of subcutaneous injection Ocrevus as treatment option for relapsing, progressi

/About-Us/MSF-News-Articles/2024/2457.aspx?lang=en-US 23/04/2024 10:47:54 a. m.